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Purpose: To investigate the effect of supplementary energy on bone formation and resorption 
during arduous military training in energy deficit. Methods: Thirty male soldiers completed 
an 8-week military combat course (mean ± SD, age 25 ± 3 years, height 1.78 ± 0.05 m, body 
mass 80.9 ± 7.7 kg). Participants received either the habitual diet (control group, n = 15) or an 
additional 5.1 MJ·d–1 to eliminate the energy deficit (supplemented group, n = 15). Circulating 
markers of bone formation and resorption, and reproductive, thyroid, and metabolic status, 
were measured at baseline, and week 6 and 8 of training. Results: Bone ALP decreased in 
controls (−4.4 ± 1.9 μg∙L-1) and increased in the supplemented group (16.0 ± 6.6 μg∙L-1), 
between baseline and week 8 (P < 0.001). P1NP increased between baseline and week 6 for 
both groups (5.6 ± 8.1 μg∙L-1, P = 0.005). βCTX decreased between baseline and week 8 for 
both groups (−0.16 ± 0.20 μg∙L-1, P < 0.001). Prolactin increased from baseline to week 8 for 
the supplemented group (148 ± 151 IU∙L-1, P = 0.041). The increase in adiponectin from 
baseline to week 8 was higher in controls (4.3 ± 1.8 mg∙L-1, P < 0.001) than the supplemented 
group (1.4 ± 1.0 mg∙L-1, P < 0.001). IGF binding protein-3 was lower at week 8 than baseline 
for controls (−461 ± 395 ng∙mL-1, P < 0.001). Conclusion: The increase in bone ALP, a marker 
of bone formation, with supplementation supports a role of energy in osteoblastic activity; the 
implications for skeletal adaptation and stress fracture risk is unclear. The mechanism is likely 
through protecting markers of metabolic, but not reproductive or thyroid, function.  
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Chronic low energy availability (energy intake minus exercise energy expenditure) increases 
bone resorption, decreases bone formation and areal bone mineral density, is detrimental to 
bone microarchitecture and mechanical strength, and increases stress fracture risk in female 
athletes (1-4). A decrease in bone formation is mediated by acute endocrine responses elicited 
by low energy availability  increased cortisol, and decreased 3,5,3-triiodothyronine (T3), 
leptin, and insulin-like growth factor 1 (IGF-1) (1, 2, 4, 5). Sustained, severe low energy 
availability downregulates the hypothalamic pituitary ovarian axis and suppresses oestradiol 
resulting in increased bone resorption (1, 2, 5). The effect of low energy availability and 
arduous exercise on bone health is a widely recognised clinical phenomenon in female athletes 
(Female Athlete Triad) (2), but there is little evidence in men who make up most of the combat 
soldier population. There is some limited evidence men experience similar metabolic responses 
to low energy availability (1, 3). 
 
Studies in male soldiers report endocrine changes during arduous military training 
characteristic of low energy availability: decreased IGF-1, testosterone, oestradiol, T3, and 
thyroxine (T4) occur after 5 days to 8 weeks of training (6-16). Energy availability is difficult 
to measure in free-living individuals, but energy deficits are estimated to be ~4.2  MJ∙d-1 over 
the 8-week US Army Ranger course (12, 13), and > 29.3 MJ∙d-1 over shorter courses (5 days) 
(6-11). Military training is a multi-stressor environment involving strenuous exercise, restricted 
energy intake, sleep deprivation, and psychological stress. Endocrine disturbances are 
recovered with ad libitum re-feeding following training (6-11, 14) and are dependent on the 
severity of energy deficit (17, 18). Additional energy intake during military training attenuated 
disturbances to the thyroid hormones (6, 9, 12) and IGF-1 axis (19), but not reproductive 
hormones (10, 12), however, the energy provision in these studies did not eliminate the energy 
deficit. Endocrine disturbances during military training are, therefore, likely mediated by 
energy deficiency and some of these disturbances may be prevented with energy 
supplementation.  
 
Endocrine disturbances during arduous military training are associated with impaired bone 
health. Markers of bone formation and whole body mineral content (BMC) decreased in men 
with energy deficits of ~4.2 MJ∙d-1 during 8 weeks of US Army Ranger training (12, 20). 
Furthermore, 61 days of energy deficit (13% body mass loss) during an Antarctic crossing 
decreased bone formation and reduced areal bone mineral density at the axial skeleton of 
female British soldiers (21). Conversely, basic military training, which elicits only mild energy 
deficiencies, improved tibial bone density, bone macro- and microstructure, and estimated bone 
strength after 8 to 13 weeks (22-24). Increased markers of bone formation also supports an 
anabolic response to basic military training (22, 23, 25).  
 
Basic military training is osteogenic at weight-bearing sites (22-24), but advanced military 
training courses and field exercises conducted in energy deficit decrease bone formation and 
increase bone resorption, and result in bone loss from the axial skeleton. We have previously 
shown that an 8-week, arduous combat course for male soldiers resulted in an energy deficit of 
2.7 MJ∙d-1 (26). The primary aim of this study was to investigate the effect of providing 
supplementary energy on bone formation and resorption during the same 8-week, arduous 
military course. Secondary aims were to examine the reproductive, thyroid, and metabolic 
hormones important in the regulation of bone formation and resorption. We hypothesised that 
training would decrease bone formation and increase bone resorption, and that supplementary 
energy would protect against these disturbances. Modifying energy status during high levels of 
physical activity may also help to better understand the Athlete Triad and Relative Energy 
Deficiency in Sport syndromes in men. 
 
Materials and Methods 
Participants 
Thirty healthy male British Army infantry soldiers participated in this unblinded, non-
randomised controlled trial. All participants were completing the 15-week British Army 
Section Commander’s Battle Course at the Infantry Battle School, Brecon, UK. The 
participants were spread across two training platoons; one platoon formed the control group (n 
= 15) and started training in November, and one platoon formed the supplemented group (n = 
15) and started training in January. There was no difference between groups for age, height, 
body mass, lean mass, or body fat (Table 1). All participants provided written informed consent 
following a verbal and written brief of the study. Ethical approval was provided by the Ministry 
of Defence Research Ethics Committee (84/Gen/09).  
 
Study Design 
The Section Commanders’ Battle Course is a 15-week training course for infantry soldiers, 
divided into two phases. The first phase is 7 weeks of classroom-based training, where 
candidates learn how to plan and conduct firing on fixed range complexes. The second phase 
is 8 weeks of physically demanding training on hilly and mountainous terrain to develop 
combat expertise in the field and is the focus of this study. Typical activities include small unit 
tactical operations, long patrols whilst carrying heavy loads, and repeated section attacks. The 
first 6 weeks of the second phase are spent in barracks with the training taking place in the 
local training area. The final 2 weeks are spent on a field exercise involving rigorous training 
and testing of the previous aspects of the course. Total energy expenditure and energy deficit 
were measured during the previous course (26). Total energy expenditure was 19.6 and 21.3 
MJ·d–1 during weeks 2 to 3 and weeks 6 to 7, total energy deficit was 2.7 MJ·d–1, and body 
mass loss was 5.1 kg (6.0%). Upon completion of the course, candidates are promoted (from 
lance corporal to corporal) to infantry section commanders. Each participant had a blood 
sample taken at baseline (week 1), and week 6 and week 8 of the second phase of the course. 




Food was provided from operational ration packs (for two meals or more) for 18 days when 
soldiers were on field exercises, and from cookhouse or container and packed meals for 37 
days when soldiers were in barracks (including two days where breakfast or dinner only were 
supplied by operational ration packs). Soldiers are provided an energy intake of 14.0 MJ·d–1 
during weeks 0 to 6 and 17.7 MJ·d–1 during weeks 6 to 8, and typically self-supplement their 
diet by 2.9 MJ·d–1 (19, 26). The control group were fed the habitual diet and the supplemented 
group received an additional 5.1 MJ·d–1 (5.7 MJ·d–1 during weeks 0 to 6, and 3.6 MJ·d–1 during 
weeks 6 to 8). Since we did not want soldiers using the nutritional supplement as an alternative 
to food they might normally self-supplement, and allowing for a small increase in food 
provision since the previous course (0.5 MJ·d–1), we provided a nutritional supplement to cover 
both the estimated energy deficit (2.7 MJ·d–1) and self-supplementation (2.9 MJ·d–1), thus 
providing 5.1 MJ·d–1. Supplementary energy during field exercises was provided with: i) one 
shelf-stable ready-to-eat self-heating main meal with water sachet, plus flapjack bar (6 day 
supply), or; ii) one shelf-stable ready-to-eat main meal, plus flapjack bar (6 day supply), or; iii) 
one shelf-stable freeze-dried main meal, plus protein bar (6 day supply). The energy content of 
each supplement combination was the same and the military training staff provided the meal 
combination best suited to each stage of field training. Supplementary energy in barracks was 
provided with individual zip lock bags containing a range of shelf-stable ready-to-eat products 
to be eaten over 24 h, including carbohydrate and protein-based recovery bars, nuts, raisins, 
flapjack, chocolate, and beef jerky. The supplement combinations consisted of ~45% 
carbohydrate, ~40% fat, and ~15% protein, which matched the composition of the habitual 
control diet. The combination of supplements was based on previously established soldier 
preferences and consultation with platoon staff. Supplement adherence was assessed by daily 
collection of all food wrappers and packaging, and weighing uneaten foods.  
 
Markers of Bone Formation and Resorption, and Endocrine Function 
Blood samples were collected by venepuncture from an antecubital vein and taken between 
05:30 and 06:00 h after an overnight fast and 12 h since the last exercise bout. Samples were 
centrifuged at 1500 g for 10 min in a refrigerated centrifuge, aspirated and aliquoted, and frozen 
at −40 °C. Samples were analysed in duplicate using commercial enzyme-linked 
immunosorbent (ELISA) assays for total IGF-1 (Immunodiagnostics Systems, UK), leptin 
(BioVendor, Czech Republic), and peptide YY (BioVendor, Czech Republic) in serum, and 
IGF binding protein-1 (IGF BP-1) (Medix Biochemica, Finland), IGF binding protein-3 (IGF 
BP-3) (R & D Systems, USA), and testosterone (DRG Instruments GmbH, Germany) in plasma 
with inter-assay CVs across the measurement range of ≤ 8%. Plasma procollagen type 1 N-
terminal propeptide (P1NP) and beta carboxy-terminal cross-linking telopeptide of type 1 
collagen (βCTX), and serum luteinising hormone (LH), follicle stimulating hormone (FSH), 
oestradiol, thyroid stimulating hormone (TSH), free T3, free T4, sex hormone‑binding globulin 
(SHBG), and prolactin were measured using electrochemiluminescence immunoassay 
(ECLIA) on the COBAS e601 analyser (Roche Diagnostics, Mannheim, Germany) according 
to the manufacturer’s instructions, with inter-assay CVs across the measurement range of ≤ 
4.0%. Serum androstenedione was analysed by liquid chromatography tandem mass 
spectrometry (LC-MS/MS), the methods were calibrated using commercial standards 
(Chromsystems, Germany) traceable to standard reference material SRM971 from the National 
Institute of Science and Technology (NIST). Samples were extracted using ISOLUTE® 
supported liquid extraction (SLE+) plates (Biotage, Sweden). The inter-assay CVs across the 
measurement range was ≤ 8%. Serum bone-specific alkaline phosphatase (bone ALP) 
concentrations were determined by MicroVue™ ELISA kit (Quidel Corporation, US), with 
inter-assay CV across the measurement range of ≤ 8%. Serum adiponectin was measured by 
ALPCO® total adiponectin ELISA kit (American Laboratory Products Company, US), with 
inter-assay CV across the measurement range of ≤ 6%. Free testosterone was estimated using 
measured total testosterone and SHBG, and assuming an albumin concentration of 4.6 g∙dL-1 
(27). Complete data were unavailable for P1NP and βCTX (control, n = 1; supplemented, n = 
4), bone ALP, peptide YY, adiponectin, and leptin (control, n = 1), LH, FSH, and oestradiol 
(control, n = 2; supplemented, n = 7), androstenedione (control, n = 1; supplemented, n = 8), 
and prolactin (control, n = 2; supplemented, n = 8) due to insufficient sample. 
 
Bone Mineral Content 
Whole-body BMC was assessed by fan-beam DXA (QDR4500A, Hologic Systems, USA) with 
participants wearing shorts and a t-shirt. Upper and lower body BMC were derived from the 
whole-body scan. Lean and fat mass have been reported previously and were used to calculate 
energy deficit over the 8-week training period using the following equation (19, 28): 
 
Energy deficit (MJ·d–1) = (Δ fat mass × 38) + (Δ lean mass × 6) / 56 
 
where Δ is the change in fat mass and lean mass, the energy densities of fat and lean mass are 
assumed to be 38 and 6 MJ·d–1, and 56 represents the study duration in days. 
 
Statistical Analysis 
All data were analysed using SPSS (v.24, SPSS Inc., USA) and initially checked for normality. 
Baseline participant characteristics were compared between groups using an independent 
samples t-test for parametric data (height, body mass, lean mass, and body fat) and a Mann-
Whitney U test for non-parametric data (age). Changes in markers of bone formation and 
resorption (P1NP, bone ALP, βCTX), reproductive hormones (LH, FSH, oestradiol, total 
testosterone, free testosterone, SHBG, prolactin, androstenedione), thyroid hormones (T3, T4, 
TSH) and metabolic markers (IGF-1, IGF BP-1, IGF BP-3, leptin, peptide YY, adiponectin) 
were compared between groups using a 2 × 3 (group [control vs supplemented] × time [baseline 
vs week 6 vs week 8]) mixed-design ANOVA. Significant group × time interactions were 
explored with separate one-way repeated measures (main effect of time) ANOVAs for each 
group (Friedman test for non-parametric data), and independent samples t-tests were used to 
compare groups at each time-point (Mann-Whitney U Test for non-parametric data). 
Significant main effects of time were explored with post hoc uncorrected pairwise comparisons 
(Wilcoxon Signed Rank Test for non-parametric data) to identify differences between time 
points. Effect sizes are presented as Cohen’s d (mean difference divided by pooled standard 
deviation) for between-group comparisons, Cohen’s dz (mean difference divided by standard 
deviation of the mean difference) for within-group comparisons, and eta squared (η2) or partial 
eta squared (ηp




All participants in the control and supplemented group completed the study. The supplemented 
group consumed 66 ± 13% of the 5.1 MJ·d–1 supplement (week 1 to 6: 64 ± 15% and week 7 
to 8: 77 ± 16%). The main reported reason for non-compliance was lack of time to consume all 
the food. Based upon changes in fat mass and lean mass, it was estimated that the control group 
experienced a greater energy deficit than the supplemented group (2.2 ± 1.1 vs 0.7 ± 1.1 MJ·d–
1, P < 0.001), as reported previously (19, 28). 
 
Markers of Bone Formation and Resorption 
All markers of bone formation and resorption are presented in Figure 1. There was a significant 
main effect of time for P1NP and βCTX (P ≤ 0.011, ηp
2 ≥ 0.177), but no effect of 
supplementation (main effect of group, P ≥ 0.269, ηp
2 ≤ 0.053; group × time interaction, P ≥ 
0.857, ηp
2 ≤ 0.007). P1NP was higher at week 6 than baseline (P = 0.005, dz = 0.73) and week 
8 (P = 0.005, dz = 0.51). βCTX was lower at week 8 than baseline (P = 0.001, dz = −0.81) and 
week 6 (P < 0.001, dz = −1.21). There was a significant group × time interaction for bone ALP 
(P < 0.001, ηp
2 = 0.795). Separate one-way ANOVAs revealed a significant main effect of time 
for bone ALP for the control (P < 0.001, η2 = 0.740) and supplemented group (P < 0.001, η2 = 
0.856). Bone ALP was lower at week 8 than baseline (P < 0.001, dz = −2.38) and week 6 (P < 
0.001, dz = −2.00) for the control group, but bone ALP was higher at week 8 than baseline (P 
< 0.001, dz = 2.43) and week 6 (P < 0.001, dz = 2.88) for the supplemented group. Bone ALP 
was higher for the supplemented group than the control group at week 8 (P < 0.001, d = 1.82).  
 
Reproductive Hormones 
All reproductive hormone data are presented in Figure 2. Testosterone has been reported 
previously (19) but is included here for completeness. There was a significant main effect of 
time for LH, FSH, oestradiol, total testosterone, free testosterone, androstenedione, and SHBG 
(all P ≤ 0.035, ηp
2 ≥ 0.162), but no effect of supplementation (main effect of group, all P ≥ 
0.2229, ηp
2 ≤ 0.069; group × time interaction, all P ≥ 0.273, ηp
2 ≤ 0.065). LH was higher at 
week 8 than baseline (P = 0.013, dz = 0.66). FSH was higher at week 8 than baseline (P < 0.001, 
dz = 1.11) and week 6 (P = 0.040, dz), and higher at week 6 than baseline (P = 0.031, dz = 0.80). 
Oestradiol, total testosterone, free testosterone, and androstenedione were lower (dz ≤ −0.46), 
and SHBG was higher (dz ≥ 0.97), at week 8 than baseline (all P ≤ 0.043) and week 6 (all P < 
0.001). Androstenedione was also higher at week 6 than baseline (P = 0.030, dz = 0.47). There 
was a significant group × time interaction for prolactin (P < 0.001, ηp
2 = 0.349). One-way 
ANOVAs revealed a significant main effect of time for prolactin for the control (P < 0.001, η2 
= 0.522) and supplemented group (P = 0.024, η2 = 0.463). Prolactin was higher at week 6 than 
baseline (P = 0.002, dz = 1.09) and week 8 (P = 0.001, dz =1.19) for the control group, but 
higher at week 8 than baseline (P = 0.041, dz = 0.98) for the supplemented group. Prolactin was 
higher at week 8 for the supplemented than the control group (P = 0.003, d = 1.09).  
 
Thyroid Hormones 
All thyroid hormone data are presented in Figure 3. There was a significant main effect of time 
for TSH and free T4 (both P ≤ 0.001, ηp
2 ≥ 0.231), but no effect of supplementation (main effect 
of group, both P ≥ 0.204, ηp
2 ≤ 0.057; group × time interaction, both P ≥ 0.295, ηp
2 ≤ 0.042). 
TSH was lower at week 8 than baseline (P = 0.016, dz =−0.46) and week 6 (P < 0.001, dz 
=−1.63), and higher at week 6 than baseline (P = 0.003, dz = 0.60). Free T4 was higher at week 
6 than baseline (P = 0.026, dz = 0.44) and week 8 (P < 0.001, dz = 0.86). There was no significant 
main effect of time (P = 0.207, ηp
2 = 0.055) and no effect of supplementation for free T3 (main 
effect of group, P = 0.069, ηp
2 = 0.113; group × time interaction, P = 0.145, ηp
2 = 0.067). 
 
Metabolic Hormones 
All metabolic hormone data are presented in Figure 4. Total IGF-1, IGF BP-1, and IGF BP-3 
have been reported previously (19) but are included for completeness. There was a significant 
main effect of time for total IGF-1 and IGF BP-1 (both P ≤ 0.009, ηp
2 ≥ 0.176), but no effect of 
supplementation (main effect of group, both P ≥ 0.307, ηp
2 ≤ 0.037; group × time interaction, 
both P ≥ 0.276, ηp
2 ≤ 0.044). Total IGF-1 was lower at week 8 than baseline (P < 0.001, dz = 
−0.96) and week 6 (P < 0.001, dz = −0.90), and higher at week 6 than baseline (P = 0.015, dz = 
0.47). IGF BP-1 was lower at week 6 than baseline (P = 0.002, dz = −0.64) and week 8 (P = 
0.003, dz = −0.62). There was a significant group × time interaction for IGF BP-3 (P = 0.017, 
ηp
2 = 0.136). Separate one-way ANOVAs revealed a significant main effect of time for IGF 
BP-3 for the control group (P < 0.001, η2 = 0.622) but not the supplemented group ( P = 0.444, 
η2 = 0.056). IGF BP-3 was lower at week 8 than baseline (P < 0.001, dz = −1.17) and week 6 
(P < 0.001, dz = −1.58). IGF BP-3 was not different between groups at any time point (P ≥ 
0.174). There was no significant main effect of time (P = 0.164, ηp
2 = 0.068) or effect of 
supplementation for peptide YY (main effect of group, P = 0.262, ηp
2 = 0.046; significant group 
× time interaction, P = 0.204, ηp
2 = 0.059). There was a significant group × time interaction for 
adiponectin (P < 0.001, ηp
2 = 0.445). Separate one-way ANOVAs revealed a significant main 
effect of time for adiponectin for the control (P < 0.001, η2 = 0.802) and supplemented group 
(P < 0.001, η2 = 0.798). Adiponectin was higher at week 8 than baseline (P < 0.001, dz = 3.24) 
and week 6 (P = 0.024, dz = 0.68), and week 6 was higher than baseline (P < 0.001, dz = 1.86) 
for the control group. Adiponectin was higher at week 6 than baseline (P < 0.001, dz = 2.38) 
and week 8 (P < 0.001, dz = 1.50), with week 8 higher than baseline (P < 0.001, dz = 1.44) for 
the supplemented group. Adiponectin was higher in the control than the supplemented group 
at week 8 (P < 0.001, d = 1.54). There was a significant main effect of time for leptin (P = 
0.006, ηp
2 = 0.198) but no effect of supplementation (main effect of group, P = 0.950, ηp
2 = 
0.000; group × time interaction, P = 0.543, ηp
2 = 0.019). Leptin was lower at week 8 then 
baseline (P = 0.005, dz = −0.58) and week 6 (P < 0.001, dz = −0.84).   
 
Bone Mineral Content 
All BMC data are presented in Figure 5. There was a significant main effect of time for upper 
body BMC (P = 0.023, ηp
2 = 0.172), but no effect of supplementation (main effect of group, P 
= 0.535, ηp
2 = 0.014; group × time interaction, P = 0.251, ηp
2 = 0.047). Upper body BMC was 
higher at week 8 then baseline. There was no significant main effect of time (P = 0.477, ηp
2 = 
0.018) and no effect of supplementation for lower body BMC (main effect of group, P = 0.526, 
ηp
2 = 0.015; group × time interaction, P = 0.547, ηp
2 = 0.013). 
 
Discussion 
This study reports the effect of supplementary energy on bone formation and resorption, and 
the endocrine regulators of bone, in male soldiers during an 8-week arduous military training 
course. Eight weeks of military training in energy deficit (control group) decreased bone 
formation and resorption, and disturbed markers of reproductive and metabolic function; 
βCTX, bone ALP, oestradiol, total testosterone, free testosterone, androstenedione, IGF-1, IGF 
BP-3, and leptin decreased, and LH, FSH, SHBG, and adiponectin increased. The smaller loss 
in lean and fat mass for the supplemented group compared with the control group, as previously 
reported, supports an attenuated energy deficit (−0.7 ± 1.1 MJ·d–1 vs −2.2 ± 1.1 MJ·d–1) (19, 
28). In the supplemented group, bone ALP and prolactin increased, IGF BP-3 was maintained, 
and the increase in adiponectin was attenuated. Supplementary energy had no other effect on 
the bone or endocrine responses to military training. The supplementary food provided an 
increase in energy and macronutrients (in the same proportions as the control diet), did not 
include foods rich in vitamin D or calcium, and, therefore, did not change diet composition. 
The only difference between groups was the provision of supplementary energy; other multi-
stressor characteristics of military training, such as strenuous exercise, sleep restriction, and 
psychological stress were unchanged and unlikely contributed to differences observed between 
groups.  
 
Markers of Bone Formation and Resorption 
We measured P1NP and bone ALP as markers of bone formation. Procollagen type 1 N-
terminal propeptide  a measure of type I collagen synthesis by the osteoblast (29)  was 
higher at week 6 compared with baseline, but not different between baseline and week 8. The 
P1NP response to training was similar between groups. Bone-specific alkaline phosphatase  
a measure of osteoblast activity and mineralisation (29)  decreased in the control, but 
increased in the supplemented group, during 8 weeks of training. Procollagen type 1 N-terminal 
propeptide and bone ALP reflect different bone formation processes, which may explain their 
different response to training and feeding. Laboratory studies show that short-term (5 days) 
low energy availability has no effect on P1NP production in men (30). We recently observed 
no change in P1NP in women following a 61 day Antarctic traverse, although the follow-up 
measurement was made 4 days after the expedition (21). Similar to this study, P1NP was 
unchanged (22, 23) or increased (25) in response to 8 to 16 weeks of basic military training in 
men and women. The influence of energy status on the bone ALP response to military training 
is also supported by other military studies. Decreased bone ALP is reported following energy 
deficit during a 61 day Antarctic traverse in women (21), and 8 weeks of US Army Ranger 
training in men (20), whereas bone ALP increased, or was unchanged, in response to 8 to 16 
weeks of basic military training in energy balance (23, 25). These studies support our finding 
that the bone ALP, but not P1NP, response to military training in men is influenced by energy 
status. Physical activity levels were similar between our control and supplemented groups (19, 
28), and so the differences in bone ALP were not due to differences in training load. Military 
combat training involves sleep deprivation. Sleep deprivation reduces bone ALP (31), 
however, both groups completed identical training programmes, and had a similar sex steroid 
response, and so sleep loss is an unlikely mechanism contributing to the differences between 
groups. We are, however, unable to determine whether differences in absolute intakes of 
nutrients, rather than energy, contributed to the increased bone ALP in the supplemented group. 
 
Bone resorption  measured by βCTX  decreased from baseline to week 8 in both groups. 
The reduction in βCTX demonstrates that training decreased type I collagen degradation 
independently of energy status. Laboratory studies show that short-term (5 days) low energy 
availability had no effect on βCTX in men (30). Military studies demonstrate no effect of 
energy deficit on the βCTX response to 8 weeks US Army Ranger training in men (20), or a 
61 day Antarctic traverse in women (21). Similar to our study, reduced βCTX has been reported 
in response to 13 weeks of infantry basic military training in men and women (22). The change 
in βCTX (and P1NP) in our study likely represents the bone modelling and/or remodelling 
response to mechanical loading (22-24). An increase in BMC, albeit small, was shown for the 
upper (1.0%), but not lower body, supporting an adaptive bone response to loading. Soldiers 
carry heavy loads with their upper-body during training that may not reflect habitual physical 
activity (unlike lower limb loading). Anticipated changes in lower limb bone in response to 
military training of this duration are unlikely picked up by DXA (2.8% increase (22)), with the 
CV of DXA appendicular bone outcomes ≤ 1.2% (unpublished data from our laboratory). We 
were, however, unable to differentiate axial from appendicular, and cortical from trabecular, 
sites. Future studies should consider imaging with high-resolution peripheral quantitative 
computed tomography to examine the effect of energy status and exercise on bone 
compartments and microarchitecture. Nevertheless, these data suggest that the type I collagen 
metabolic response (P1NP and βCTX) to military training is independent of energy status, 
whereas bone ALP, indicative of osteoblast activity and bone mineralisation, increases with 
supplementary energy. Markers of bone formation and resorption cannot distinguish between 
bone modelling or remodelling, but supplementary energy may promote the formation of new 
bone in response to mechanical loading via bone modelling. Supplementary energy during 
arduous exercise may, therefore, be a strategy for reducing stress fracture risk without 
compromising training; an increase in new bone formation with mechanical loading will 
increase bone fatigue resistance (32) and reduce stress fracture risk. The mechanism for the 
increase in bone ALP with supplementary energy could be due to protective effects of feeding 
on reproductive, thyroid, and metabolic function (1, 2, 4, 5). 
 
Reproductive Hormones 
Military training decreased oestradiol, total testosterone, free testosterone, and 
androstenedione, and increased SHBG. These changes in sex steroid hormones were 
accompanied by an increase in the gonadotropins LH and FSH, which is in contrast to other 
military studies with more severe energy deficits (8, 12, 14, 17, 33). Low testosterone initiates 
a positive feedback loop to the hypothalamic pituitary gonadal axis, and gonadotropins increase 
to maintain normal testosterone concentrations. The sex steroids, oestradiol and testosterone, 
are important regulators of bone (34). Oestradiol suppresses osteoclast activity (34) and low 
concentrations of oestradiol with energy deficiency increase bone resorption in active women 
(1, 2, 5). The effect of energy restriction on sex steroid concentrations and bone in men is less 
well understood (1, 3), but sex differences in these responses has important considerations for 
the military. We observed a reduction in bone resorption despite reduced oestradiol and 
testosterone, and increased SHBG, possibly indicating that men are more resistant to the effect 
of energy deficiency than women (30) or mechanical loading was protective. Sex steroid 
hormones, and bone formation and resorption markers do, however, each have an independent 
relationship with the severity of energy restriction (5). 
 
Supplementary energy had no protective effect on the sex steroid hormone response to military 
training. Military training studies consistently demonstrate that energy deficits (5 days to 8 
weeks of 4.2 to ≥ 29.3 MJ∙d-1) increase SHBG, and reduce oestradiol, testosterone, 
androstenedione, and prolactin (7, 8, 10-15, 17, 18, 35), in agreement with our data. The few 
military training studies that have provided supplementary energy found no protective effect 
on sex steroid concentrations (10, 12, 35), also consistent with our data. Supplementary energy 
was likely not protective of sex steroids in our study, and these previous studies, because the 
additional energy was insufficient to eliminate the energy deficit or mechanisms other than 
energy deficiency, such as sleep deprivation (11) or high levels of physical activity, were 
responsible for the reduction in sex steroid concentrations. Supplementary energy did, 
however, increase prolactin at week 8. Prolactin increases bone formation directly through 
receptors on osteoblasts or indirectly through interactions with other reproductive hormones 
(36), and could explain the increase in bone ALP with supplementation. These reproductive 
hormone data, nevertheless, demonstrate that the increase in bone formation with additional 
energy intake is not due to the protection of sex steroid hormone concentrations. 
 
Thyroid Hormones 
Military training had minimal effect on thyroid hormones in either group; thyroid stimulating 
hormone was lower at week 8 than baseline but free T3 and free T4 were not reduced. Short 
periods of military training in energy deficit (≤ 7 days) reduce TSH, T3, and/or T4 (6, 9, 11, 
18), which is prevented by increasing energy intake to attenuate the energy deficit (9). The 8-
week US Army Ranger course increased TSH (12, 14, 15), decreased T3 and T4 (12, 14), or 
did not affect T3 (15); periodic re-feeding during the course recovered low T3 concentrations 
(12). The thyroid hormone, T3, stimulates osteoblast proliferation and differentiation, and bone 
mineralisation (37), and reductions in T3 contribute to reduced bone formation with energy 
deficit (2). The energy deficit in this study may not have been severe enough to reduce T3, and 
similar thyroid responses between groups demonstrate that impaired thyroid function cannot 
explain differences in bone formation between groups. 
 
Metabolic Hormones 
Military training altered the IGF axis; total IGF-1 and IGF-BP 3 were lower at week 8 
compared with baseline and week 6, and IGF-BP 1 was higher at week 8 compared with week 
6 in the control group. The 8-week US Army Ranger course reduced total IGF-1, increased 
IGF-BP 1 and, in contrast to our data, increased IGF-BP 3 (12-15). A reduction in total IGF-1 
and IGF-BP 3 is shown in other studies examining several days of military training in energy 
deficit (16, 38). Supplementary energy had no effect on the total IGF-1 or IGF BP-1 response 
to training, but did maintain IGF BP-3 in our study. In contrast, total IGF-1 increased with 
periods of re-feeding during US Army Ranger training (12). Insulin-like growth factor 1 is an 
important regulator of bone formation (39, 40), and decreases in total IGF-1 with energy 
restriction contribute to decreases in bone formation (1, 2, 5). The actions of the IGF binding 
proteins on bone are complex; IGF binding proteins regulate the bioavailability and local 
actions of IGF-1, but also act directly (39, 40). Insulin-like growth factor binding protein 1 is 
primarily inhibitory by preventing the binding of IGF-1 to the receptor, and IGF-BP 3 increases 
the bioavailability of circulating IGF-1 by making a tertiary complex, and directly stimulates 
osteoblasts (39). Maintaining IGF BP-3 with supplementary feeding may have contributed to 
the increase in bone ALP. Military training also decreased leptin and increased adiponectin, 
characteristic of energy deficiency (3). Leptin directly stimulates osteoblasts and can act 
indirectly on bone though effects on oestradiol, cortisol, IGF-1, and parathyroid hormone (41), 
whereas adiponectin can inhibit osteoblast activity (40). Supplementary energy had no effect 
on the leptin response to training but attenuated the increase in adiponectin, which may have 
decreased inhibition of osteoblast activity and contributed to the increase in bone ALP. These 
conclusions are speculative, but the data provide some evidence for the mechanism by which 
supplementary energy supports the adaptive bone formation response to military training. 
 
Limitations 
This study was a non-randomised trial; the control group completed training first (starting in 
November) and the supplemented group completed training in the subsequent course (starting 
in January). We opted against a randomised design trial to reduce the risk of those allocated to 
the control condition from supplementing their diet. The reported differences in bone formation 
and endocrine function between groups could, therefore, be due to differences between courses 
and time of year. Both courses followed identical training programmes, as shown by similar 
physical activity levels, and completed training in winter, and, therefore, we are confident 
differences between groups are due to energy status. The direct measurement of energy intake 
or expenditure was not possible, but the changes in body composition confirm supplementary 
energy was effective in attenuating the energy deficit compared with the control group. It is 
also possible that our bone ALP assay had some cross-reactivity with the liver ALP isoform, 
but the level of reactivity is low (< 8%) and unlikely explains our findings. Finally, the 
conclusions in this study are limited by the small sample size. 
 
Conclusion 
Supplementary energy, equal to two thirds of the calculated energy deficit, increased bone ALP 
(a marker of bone formation) in response to 8-weeks military training. The mechanism for this 
increase in bone ALP is unclear but could be due to an indirect effect of feeding on osteoblast 
function via increased prolactin, maintenance of IGF BP-3 and attenuation of adiponectin. The 
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List of Figures 1 
 2 
Figure 1. Markers of bone formation and resorption. A, procollagen 1 N-terminal propeptide 3 
(P1NP); B, bone-specific alkaline phosphatase (bone ALP); C, beta C-telopeptide cross-links 4 
of type 1 collagen (βCTX).  5 
aP < 0.05 vs baseline for control; bP < 0.05 vs baseline for supplemented; cP < 0.05 vs week 6 for control; dP < 6 
0.05 vs week 6 for supplemented; eP < 0.05 vs control at same time-point. 7 
 8 
Figure 2. Reproductive hormones. A, luteinising hormone (LH); B, follicle stimulating 9 
hormone (FSH); C, oestradiol; D, total testosterone; E, free testosterone; F, androstenedione; 10 
G, prolactin; H, sex hormone binding globulin (SHBG).   11 
aP < 0.05 vs baseline for control; bP < 0.05 vs baseline for supplemented; cP < 0.05 vs week 6 for control; dP < 12 
0.05 vs week 6 for supplemented; eP < 0.05 vs control at same time-point. 13 
 14 
Figure 3. Thyroid hormones. A, thyroid stimulating hormone (TSH); B, free 3,5,3-15 
triiodothyronine (T3); C, free thyroxine (T4).  16 
aP < 0.05 vs baseline for control; bP < 0.05 vs baseline for supplemented; cP < 0.05 vs week 6 for control; dP < 17 
0.05 vs week 6 for supplemented; eP < 0.05 vs control at same time-point. 18 
 19 
Figure 4. Metabolic markers for the control (left panels) and supplemented (right panels) 20 
groups. A, insulin-like growth factor 1 (IGF-1); B, insulin-like growth factor binding protein 1 21 
(IGF BP-1); C, insulin-like growth factor binding protein 3 (IGF BP-3); D, peptide YY; E, 22 
adiponectin; F, leptin.  23 
aP < 0.05 vs baseline for control; bP < 0.05 vs baseline for supplemented; cP < 0.05 vs week 6 for control; dP < 24 
0.05 vs week 6 for supplemented; eP < 0.05 vs control at same time-point. 25 
 26 
Figure 5. Bone mineral content (BMC). A, upper body BMC; B, lower body BMC.  27 
aP < 0.05 vs baseline for control; bP < 0.05 vs baseline for supplemented 28 
